Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX

Journal of Inherited Metabolic Disease

Volumn 27, Issue 1, 2004, Pages 1-9

  Cabrera Abreu, J ^a   Crabtree, N J ^b   Elias, E ^b   Fraser, W ^c   Cramb, R ^b   Alger, S ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; DEOXYPYRIDINOLINE; PEPTIDE DERIVATIVE; PROCOLLAGEN; PYRIDINOLINE;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BONE DENSITY; BONE DESTRUCTION; BONE MINERAL; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION FUNCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; MALE; OSTEOPOROSIS; RANDOMIZATION; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; DENSITOMETRY, X-RAY; FEMALE; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE I; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; MALE;

EID: 1842433788     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BOLI.0000016632.13234.56     Document Type: Article

References (14)

1. Blumsohn A, Eastell R (1997) The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice? Ann Clin Biochem 34: 449-459.
2. Calvo M, Eyre D, Gundberg C (1996) Molecular basis and clinical application of biological markers of bone turnover. Endo Rev 17: 333-368.
3. Folk CC, Greene HL (1984) Dietary management of type I glycogen storage disease. J Am Diet Assoc 84: 293-301.
4. Glorieux FX (2001) The use of bisphosphonates in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab 14 (supplement 6): 1491-1495.
5. Kishani PS, Boney A, Chen YT (1999) Nutritional deficiencies in a patient with glycogen storage disease type Ib. J Inherit Metab Dis 22: 795-801.
6. Lee P, Leonard J (1995) The hepatic glycogen storage diseases - problems beyond childhood. J Inherit Metab Dis 18: 462-472.
7. Lee P, Patel J, Fewtrell M, et al (1999) Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 154: 483-487.
8. Miller JH, Stanley P, Gates GF (1979) Radiography of glycogen storage diseases. Am J Roentgenol 132: 379-387.
9. Preger L, Sanders GW, Gold RH, et al (1969) Roentgenographic skeletal changes in the glycogen storage diseases. Radiology 107: 840-847.
10. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ (1991) Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone disease. Eur J Clin Invest 21: 310-315.
11. Ross P, Knowlton W (1998) Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 13: 297-302.
12. Schwahn B, Rauch F, Wendel U, Schonau E (2002) Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. J Pediatr 141: 308-310.
13. Shaaraway M, El-Dawakhly AS, Mosaad M, et al (1999) Biomarkers of bone turnover and bone mineral density in hyperprolactinaemic amenorrheic women. Clin Chem Lab Med 37: 433-438.
14. Vesper H, Demers L, Eastell R, Garnero P, Kleerekoper M, Robins S (2002) Assessment on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. Clin Chem 48: 220-235.